Predicting and Understanding Cancer Response to Treatment

Dis Markers. 2018 May 29:2018:6159214. doi: 10.1155/2018/6159214. eCollection 2018.

Authors

Maurizio Callari¹, Paolo Gandellini², Ira Skvortsova³, Paul N Span⁴

Affiliations

¹ Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
² Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
³ Innsbruck Medical University, Innsbruck, Austria.
⁴ Radiotherapy & OncoImmunology Laboratory, Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, Netherlands.

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Antineoplastic Agents / therapeutic use
Biomarkers, Tumor / genetics*
Humans
Neoplasms / drug therapy
Neoplasms / genetics*
Pharmacogenomic Variants
Prognosis
Treatment Outcome

Substances

Antineoplastic Agents
Biomarkers, Tumor